Concepedia

Tim Fessenden

TF

Statistics

Publications

7

Citations

733

H-Index

7

Active since

2009

Affiliations

University of California, San Francisco(Current)

Massachusetts Institute of Technology

Ragon Institute of MGH, MIT and Harvard

University of Chicago

Koch Institute for Integrative Cancer Research At MIT

Tim Fessenden is an author at University of California, San Francisco specializing in oncology, medicine, and immunology.

ORCID

Publications per year

2009–2022

7

Publications

7

Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity

Ellen Duong, Tim Fessenden, Emi A. Lutz et al. · Immunity · 2021 · 356 citations · Full text

, , +10

Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer

Steven Kregel, James L. Chen, Westin R. Tom et al. · Oncotarget · 2016 · 136 citations · Full text

, , +15

Deciphering the immunopeptidome in vivo reveals new tumour antigens

Alex M. Jaeger, Lauren Stopfer, Ryuhjin Ahn et al. · Nature · 2022 · 104 citations · Full text

, , +12

Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes

Colleen Fordyce, Kelley T. Patten, Tim Fessenden et al. · Breast Cancer Research · 2012 · 51 citations · Full text

, , +17

DNA Damage Drives an Activin A–Dependent Induction of Cyclooxygenase-2 in Premalignant Cells and Lesions

Colleen Fordyce, Tim Fessenden, Curtis R. Pickering et al. · Cancer Prevention Research · 2009 · 41 citations · Full text

, , +17

1–5 of 7